Literature DB >> 19816815

VEGF -460C>T polymorphism and cancer risk: a meta-analysis.

Bin Xu1, Ning-Han Feng, Na Tong, Zi-Dun Wang, Wei Zhang, Hong-Fei Wu, Lin-Xin Hua.   

Abstract

Vascular endothelial growth factor (VEGF) is a major driver of physiological and pathological angiogenesis and plays important roles in the etiology and metastasis of cancers. The -460C>T polymorphism in VEGF gene region has been implicated in cancer risk and related to VEGF expression. However, published data remain conflicting. To derive a more precise estimation, a meta-analysis of 5,863 cases and 5,276 controls from 14 published case-control studies was performed. Odds ratios (ORs) with 95% confidence intervals (CIs) were estimated to assess the association. VEGF -460T represented a risk factor for cancers in Asians (OR=1.69, 95% CI: 1.09-2.62) but not in Europeans (OR=0.92, 95% CI: 0.78-1.08). Our meta-analysis showed the evidence that VEGF -460T was associated with increased cancer risk in Asians. Further prospective researches with larger numbers of worldwide participants are expected to validate this result.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19816815     DOI: 10.1007/s12032-009-9329-2

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  26 in total

Review 1.  Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis.

Authors:  A Saaristo; T Karpanen; K Alitalo
Journal:  Oncogene       Date:  2000-12-11       Impact factor: 9.867

2.  No association between polymorphism in the vascular endothelial growth factor gene at position -460 and sporadic prostate cancer in the Turkish population.

Authors:  Ilke H Onen; Ece Konac; Muzaffer Eroglu; Cagri Guneri; Hasan Biri; Abdullah Ekmekci
Journal:  Mol Biol Rep       Date:  2007-01-11       Impact factor: 2.316

3.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

4.  Vascular endothelial growth factor polymorphisms -1154 G/A and -460 C/T are not associated with VEGF mRNA expression and susceptibility to sporadic colon cancer.

Authors:  Tamara Cacev; Bozo Loncar; Sven Seiwerth; Sime Spaventi; Sanja Kapitanovic
Journal:  DNA Cell Biol       Date:  2008-10       Impact factor: 3.311

5.  Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms--a case-control study in an Omani population.

Authors:  Mansour S Al-Moundhri; Maryam Al-Nabhani; Ikram A Burney; Abdul-Aziz Al-Farsi; Bassim Al-Bahrani
Journal:  Mol Carcinog       Date:  2009-12       Impact factor: 4.784

6.  Association study of vascular endothelial growth factor gene polymorphisms in endometrial carcinomas in a Japanese population.

Authors:  M Amano; S Yoshida; S Kennedy; N Takemura; M Deguchi; N Ohara; T Maruo
Journal:  Eur J Gynaecol Oncol       Date:  2008       Impact factor: 0.196

7.  Lack of association between -460 C/T and 936 C/T of the vascular endothelial growth factor and angiopoietin-2 exon 4 G/A polymorphisms and ovarian, cervical, and endometrial cancers.

Authors:  Ece Konac; H Ilke Onen; Jale Metindir; Ebru Alp; Aydan Asyali Biri; Abdullah Ekmekci
Journal:  DNA Cell Biol       Date:  2007-07       Impact factor: 3.311

8.  Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival.

Authors:  Konstantinos Dassoulas; Maria Gazouli; Spyros Rizos; George Theodoropoulos; Zoi Christoni; Nikolaos Nikiteas; Petros Karakitsos
Journal:  Mol Carcinog       Date:  2009-06       Impact factor: 4.784

9.  Influence of VEGF-A gene variation and protein levels in breast cancer susceptibility and severity.

Authors:  Sabapathy P Balasubramanian; Angelo Cox; Simon S Cross; Sue E Higham; Nicola J Brown; Malcolm W Reed
Journal:  Int J Cancer       Date:  2007-09-01       Impact factor: 7.396

10.  Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3.

Authors:  V Vincenti; C Cassano; M Rocchi; G Persico
Journal:  Circulation       Date:  1996-04-15       Impact factor: 29.690

View more
  11 in total

1.  Polymorphism of vascular endothelial growth factor -1154G>A (rs1570360) with cancer risk: a meta-analysis of 16 case-control studies.

Authors:  Ting-Ting Hong; Ru-Xia Zhang; Xiao-Hong Wu; Dong Hua
Journal:  Mol Biol Rep       Date:  2011-12-14       Impact factor: 2.316

2.  Vascular endothelial growth factor (VEGF) gene polymorphisms and risk of head and neck cancer: a meta-analysis involving 2,444 individuals.

Authors:  Wei-Dong Leng; Mei-Ni He; Qi-Lin Chen; Heng Gong; Li Zhang; Xian-Tao Zeng
Journal:  Mol Biol Rep       Date:  2013-09-21       Impact factor: 2.316

3.  Meta-analysis of the association between VEGF-634 G>C and risk of malignancy based on 23 case-control studies.

Authors:  Liu Liu; Lin Liu; Fei Zeng; Kai Wang; Jun Huang; Lin Xin; Pei-Qian Zhu
Journal:  J Cancer Res Clin Oncol       Date:  2010-12-21       Impact factor: 4.553

4.  Genetic variation in VEGF family genes and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study.

Authors:  Alicia Beeghly-Fadiel; Xiao-Ou Shu; Wei Lu; Jirong Long; Qiuyin Cai; Yong-Bing Xiang; Ying Zheng; Zhongming Zhao; Kai Gu; Yu-Tang Gao; Wei Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-11-30       Impact factor: 4.254

5.  Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancer.

Authors:  Y Sunakawa; S Stremitzer; S Cao; W Zhang; D Yang; T Wakatsuki; Y Ning; S Yamauchi; S Stintzing; A Sebio; R El-Khoueiry; S Matsusaka; A Parekh; A Barzi; M Azuma; M Watanabe; W Koizumi; H-J Lenz
Journal:  Ann Oncol       Date:  2014-11-18       Impact factor: 32.976

6.  Polymorphism of vascular endothelial growth factor -2578C/A with cancer risk: evidence from 11263 subjects.

Authors:  Chao Cao; Tao Ying; Jing-Jing Fang; Shi-Fang Sun; Dan Lv; Zhong-Bo Chen; Hong-Ying Ma; Yi-Ming Yu; Qun-Li Ding; Li-Hua Shu; Zai-Chun Deng
Journal:  Med Oncol       Date:  2010-07-16       Impact factor: 3.064

7.  Polymorphism of VEGF-460C/T associated with the risk and clinical characteristics of lung cancer in Chinese population.

Authors:  Shi-Fang Sun; Da-Bing Huang; Chao Cao; Zai-Chun Deng
Journal:  Med Oncol       Date:  2013-01-04       Impact factor: 3.064

8.  Vascular endothelial growth factor (VEGF) -2578C/A and -460C/T gene polymorphisms and lung cancer risk: a meta-analysis involving 11 case-control studies.

Authors:  Ning Song; Bao Liu; Jianling Wu; Rufang Zhang; Lin Duan; Wenshu He; Congmin Zhang
Journal:  Tumour Biol       Date:  2013-08-28

9.  Positive association of the vascular endothelial growth factor-A +405 GG genotype and poor survival in stage I-II gastric cancer in the Northern Chinese population.

Authors:  Ailin Li; Peng Gao; Zhenning Wang; Yongxi Song; Yingying Xu; Yuan Miao; Jinliang Zhu; Huimian Xu
Journal:  Mol Biol Rep       Date:  2012-12-23       Impact factor: 2.316

10.  Association of vascular endothelial growth factor, transforming growth factor beta, and interferon gamma gene polymorphisms with proliferative diabetic retinopathy in patients with type 2 diabetes.

Authors:  Suman Kalyan Paine; Analabha Basu; Lakshmi Kanta Mondal; Aditi Sen; Subhadip Choudhuri; Imran Hussain Chowdhury; Avijit Saha; Gautam Bhadhuri; Ankur Mukherjee; Basudev Bhattacharya
Journal:  Mol Vis       Date:  2012-11-17       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.